NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported second-quarter revenue growth of 6 percent, with increases coming from all of its reporting units.

The St. Louis-based chemicals and research products firm reported total revenues of $554 million for the three-month period ended June 30, compared to $522 million for the second quarter of 2009. Excluding the impact of currency exchange, Sigma-Aldrich's sales were up 7 percent for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.